Evidence map›Paper›PMID 33931097›Full record

SynthesisOrphanet journal of rare diseases2021

A systematic review of case reports of hepatic actinomycosis.

Zahra Chegini, Mojtaba Didehdar, Seidamir Pasha Tabaeian, Amin Khoshbayan, Aref Shariati

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Concurrent Hepatic Abscess and Pleural Empyema due toCase reports in infectious diseases · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Rheumatoid arthritis complicated with cervical actinomycosis and ureteral obstruction: A case report and literature review.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  16. A 60-Year Literature Review on Hepatic Actinomycosis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zahra CheginiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mojtaba DidehdarDepartment of Medical Parasitology and Mycology, Arak University of Medical Sciences, Arak, Iran.
Seidamir Pasha TabaeianDepartment of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Amin KhoshbayanDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Aref ShariatiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. arefshariati0111@sbmu.ac.ir.ORCID 0000-0003-1680-0427
Iran University of Medical Sciences · IRArak University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatic Actinomycosis (HA) is one of the infections that causes disorders in patients when diagnosed untimely and inappropriately.

methodsCase reports on HA in patients published between 2000 and April 2020 were gathered by carrying out a structured search through PubMed/Medline.

resultsThrough a survey of the Medline database, 130 studies were identified and then, 64 cases with HA were included in the final analysis. Asia had the largest share of cases with 37.5% (24 reports), followed by Europe and the Americas. Affected patients were predominantly males (64%) and the overall mortality rate was 1% with only one male patient in his 50 s dying. Nearly all patients (92%) were immunocompetent. However, in four patients, the use of immunosuppressive medication led to depression of the immune system. Most of the patients (80%) experienced complications. In terms of the complications, the most frequent ones were previous history of abdominal surgery (32%) and foreign bodies in the abdominopelvic region (20%). Actinomyces israelii was the most common pathogen isolated from patients. Abdominal pain (66%), fever (62%), weight loss (48%), night sweat, malaise, and anorexia (14%) over about 3.1 months were the most frequently reported clinical symptoms. Extension to one or more surrounding organs was evident in 18 patients (28%). Histopathologic examination confirmed infection in 67% of the patients and samples obtained from liver puncture biopsy (32%) were most frequently used in diagnosis. Surgery or puncture drainage + anti-infection was the most common method to treat patients and penicillin, Amoxicillin, Doxycycline, and ampicillin were the most frequently used drugs to control infection.

conclusionHA should be considered in patients with a subacute or chronic inflammatory process of the liver. With accurate and timely diagnosis of infection, extensive surgery can be prevented.

Indexed as

ActinomycesActinomycosisAsiaEuropeHumansMaleActinomyces speciesActinomycosisDiagnosisHepatic actinomycosisLiver abscess

Identifiers

PMID33931097
PMCPMC8086304
OpenAlexW3159532048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.